Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon Inc. stock logo
ALC
Alcon
$89.06
-1.0%
$82.56
$69.44
$90.00
$43.92B0.92907,030 shs595,113 shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$154.28
+1.1%
$152.49
$143.13
$175.97
$371.30B0.557.38 million shs7.22 million shs
STAAR Surgical stock logo
STAA
STAAR Surgical
$42.62
-1.2%
$43.09
$26.66
$65.07
$2.09B0.8717,518 shs296,906 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon Inc. stock logo
ALC
Alcon
+0.77%+11.96%+10.94%+15.48%+11.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.89%+2.52%+3.53%-3.31%-4.17%
STAAR Surgical stock logo
STAA
STAAR Surgical
-1.17%+5.17%-6.66%+37.96%-30.23%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon Inc. stock logo
ALC
Alcon
3.0578 of 5 stars
2.34.00.80.03.20.82.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.923 of 5 stars
3.23.04.23.93.12.51.9
STAAR Surgical stock logo
STAA
STAAR Surgical
4.4595 of 5 stars
2.23.00.04.12.93.32.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon Inc. stock logo
ALC
Alcon
2.67
Moderate Buy$94.715.84% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8614.28% Upside
STAAR Surgical stock logo
STAA
STAAR Surgical
2.40
Hold$47.139.95% Upside

Current Analyst Ratings

Latest STAA, ALC, and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00
5/15/2024
Alcon Inc. stock logo
ALC
Alcon
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$89.00 ➝ $94.00
5/15/2024
Alcon Inc. stock logo
ALC
Alcon
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$95.00 ➝ $104.00
5/15/2024
Alcon Inc. stock logo
ALC
Alcon
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$95.00 ➝ $100.00
5/15/2024
Alcon Inc. stock logo
ALC
Alcon
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$100.00 ➝ $105.00
5/15/2024
Alcon Inc. stock logo
ALC
Alcon
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$103.00
5/14/2024
Alcon Inc. stock logo
ALC
Alcon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$98.00 ➝ $98.00
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$46.00 ➝ $43.00
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$33.00 ➝ $40.00
5/8/2024
STAAR Surgical stock logo
STAA
STAAR Surgical
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$53.00 ➝ $55.00
(Data available from 5/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon Inc. stock logo
ALC
Alcon
$9.46B4.67$5.80 per share15.43$41.83 per share2.14
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.35$13.90 per share11.07$29.09 per share5.29
STAAR Surgical stock logo
STAA
STAAR Surgical
$326.24M6.45$0.72 per share59.53$7.99 per share5.36

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon Inc. stock logo
ALC
Alcon
$974M$2.1142.4125.792.0710.96%6.92%4.76%8/20/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.5914.092.4945.26%36.70%15.07%7/18/2024 (Estimated)
STAAR Surgical stock logo
STAA
STAAR Surgical
$21.35M$0.31138.2682.42N/A4.69%6.83%5.45%8/7/2024 (Estimated)

Latest STAA, ALC, and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2024N/A
Alcon Inc. stock logo
ALC
Alcon
$0.72$0.78+$0.06$1.06$2.46 billion$2.46 billion
5/7/2024Q1 24
STAAR Surgical stock logo
STAA
STAAR Surgical
$0.05-$0.07-$0.12-$0.07$75.34 million$77.40 million    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/27/2024Q4 2023
Alcon Inc. stock logo
ALC
Alcon
$0.68$0.70+$0.02$0.54$2.34 billion$2.33 billion  
2/26/2024Q4 23
STAAR Surgical stock logo
STAA
STAAR Surgical
$0.17$0.16-$0.01$0.32$75.94 million$76.27 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon Inc. stock logo
ALC
Alcon
N/AN/AN/AN/A3 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.09%+5.70%29.68%63 Years
STAAR Surgical stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A

Latest STAA, ALC, and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
5/10/2024
Alcon Inc. stock logo
ALC
Alcon
annual$0.15600.21%5/14/20245/15/20245/16/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon Inc. stock logo
ALC
Alcon
0.22
2.28
1.34
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.94
STAAR Surgical stock logo
STAA
STAAR Surgical
N/A
5.84
5.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alcon Inc. stock logo
ALC
Alcon
53.86%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
STAAR Surgical stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Alcon Inc. stock logo
ALC
Alcon
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
STAAR Surgical stock logo
STAA
STAAR Surgical
1.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon Inc. stock logo
ALC
Alcon
25,000493.10 millionN/AOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
STAAR Surgical stock logo
STAA
STAAR Surgical
1,11549.13 million48.64 millionOptionable

STAA, ALC, and JNJ Headlines

Recent News About These Companies

Masimo, Staar Fall On Revenue Outlooks
STAAR Surgical announces general counsel
What 7 Analyst Ratings Have To Say About Staar Surgical
Staar Surgical: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alcon logo

Alcon

NYSE:ALC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
STAAR Surgical logo

STAAR Surgical

NASDAQ:STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.